Vir Biotechnology (VIR) Net Margin (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vir Biotechnology | 1.33 Bn | 1.33 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.34 Mn |
| Dec 31, 2025 | 6.79 Mn |
| Sep 30, 2025 | -5.88 Mn |
| Jun 30, 2025 | -515,026.00 |
| Mar 31, 2025 | -314,438.00 |
| Dec 31, 2024 | 813,447.00 |
| Sep 30, 2024 | -447,961.00 |
| Jun 30, 2024 | -437,384.00 |
| Mar 31, 2024 | 56,459.00 |
| Dec 31, 2023 | 550,138.00 |
| Sep 30, 2023 | -106,252.00 |
| Jun 30, 2023 | -490,590.00 |
| Mar 31, 2023 | -1,817.00 |
| Dec 31, 2022 | -25,244.00 |
| Sep 30, 2022 | 23,508.00 |
| Jun 30, 2022 | -23,035.00 |
| Mar 31, 2022 | -2,255.00 |
| Dec 31, 2021 | -4,195.00 |
| Sep 30, 2021 | 6,985.00 |
| Jun 30, 2021 | 858,486.00 |
| Mar 31, 2021 | -181,601.00 |
| Dec 31, 2020 | -234,369.00 |
| Sep 30, 2020 | -431,645.00 |
| Jun 30, 2020 | 127,884.00 |
| Mar 31, 2020 | 515,642.00 |
| Dec 31, 2019 | -306,362.00 |
| Sep 30, 2019 | -178,617.00 |
| Jun 30, 2019 | -87,433.00 |
| Mar 31, 2019 | 6,119.00 |
| Dec 31, 2018 | 31,535.00 |